Medtronic, a medical device company, agreed to acquire the left-heart access portfolio of Acutus Medical, an arrhythmia care services provider, for $50m. “This set of initiatives is an important milestone for Acutus and is the result of the strategic reprioritization we announced earlier this year. The extended maturity from our refinancing along with proceeds from the definitive agreement to sell our left-heart access portfolio will allow us to intensify our focus on driving the adoption of our electrophysiology mapping and therapy solutions as well as improving our operational and financial performance," Vince Burgess, Acutus Medical CEO.